Scandinavian Real Hearts (private company)

See something wrong or missing? Let us know
Offices:
Västerås
Business model:
B2B B2C (Retail)
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Scandinavian Real Hearts develop a heart pump (Total Artificial Heart), with better function than those available on the market, which can primarily be used as a transitional solution for patients waiting for a heart transplant. The basic idea is that Real Hearts heart pump to pump as much like the natural heart as possible.

Companies with similar profile to Scandinavian Real Hearts:

CompanyCriteria
Denmark Antag
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland Dispelix
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland Valkee
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Iconovo
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Iceland Key Natura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Bioservo Technologies
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland WellO2
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Sweden Monocl
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Oncology Venture
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Oura Health
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Minim one investor from outside Scandinavia: Yes
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Cytovation
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Cortrium
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Modus Therapeutics
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Wheelys Café
43%
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Norway Nurx
43%
  • Similar verticals: Health services
  • Similar business models: B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Plejd
43%
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes